Fidelity Advisor Biotechnology Fund
Fidelity Advisor Biotechnology Fund (FBTTX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
fbttx · pe ratio · data through Jun 9, 2026
Core PE Ratio Metrics
Trailing 12 months · TTMInsufficient PE history data (fewer than 3 valid fiscal years).
PE Ratio vs Peers
Asset Management · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Fidelity Advisor Biotechnology FundYou FBTTX | $1.9B | N/A | — | — |
 Fidelity Advisor China Region Fund Class C FCHKX | $2.7B | N/A | — | — |
 Fidelity Advisor Diversified International Fund FDVIX | $1.8B | N/A | — | — |
 Fidelity China Region Fund FHKIX | $2.7B | N/A | — | — |
 Fidelity Utilities Fund FIUIX | $1.4B | N/A | — | — |
 Federated Hermes MDT Large Cap Value Fund FMSTX | $1.8B | N/A | — | — |
 Fidelity International Small Cap Opportunities Fund FSCOX | $1.7B | N/A | — | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Fidelity Advisor Biotechnology Fund (FBTTX) measures how much investors pay for each dollar of the company's trailing earnings. FBTTX's current PE ratio of N/A is calculated by dividing its stock price of $33.81 by its TTM earnings per share of —.
Frequently asked questions
FBTTX pe ratio · 6 questionsFBTTX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $33.81 and TTM EPS of —. Data sourced from Financial Modeling Prep via FBTTX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Fidelity Advisor Biotechnology Fund SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09